Related Experiment Video
Updated: Apr 16, 2026
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020
Donna A Messner1, Penny Mohr2, Adrian Towse3
1Center for Medical Technology Policy, World Trade Center Baltimore, 401 East Pratt Street, Suite 631, Baltimore, MD 21202, USA.
Aim:
Explore key factors influencing future expectations for the production of evidence from comparative effectiveness research for drugs in the USA in 2020 and construct three plausible future scenarios.
Materials & Methods:
Semistructured key informant interviews and three rounds of modified Delphi with systematic scenario-building methods.
Results & Conclusion:
Most influential key factors were: health delivery system integration; electronic health record development; exploitation of very large databases and mixed data sources; and proactive patient engagement in research. The scenario deemed most likely entailed uneven development of large integrated health systems with pockets of increased provider risk for patient care, enhanced data collection systems, changing incentives to do comparative effectiveness research and new opportunities for evidence generation partnerships.
